Ftse Mib
32.929,39
0,81%
DAX
18.068,21
0,26%
S&P 500
5.473,23
0,77%
NASDAQ
17.874,70
1,05%
Bitcoin
66.264,13
-0,55%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSXV Hls Therapeutics (HLS) Hls Therapeutics (HLS) Notizie

HLS

Hls Therapeutics (HLS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:HLS
DataOraFonteTitoloSimboloCompagnia
19/02/201912:30PR Newswire (Canada)HLS Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare ConferenceTSXV:HLSHls Therapeutics
06/02/201912:30PR Newswire (Canada)HLS Therapeutics Announces Graduation to the Toronto Stock ExchangeTSXV:HLSHls Therapeutics
29/01/201912:30PR Newswire (Canada)HLS Therapeutics Receives Conditional Approval to Graduate to the Toronto Stock ExchangeTSXV:HLSHls Therapeutics
15/11/201812:30PR Newswire (Canada)HLS Therapeutics Announces Q3 2018 Financial ResultsTSXV:HLSHls Therapeutics
12/11/201812:30PR Newswire (Canada)HLS Therapeutics Announces that Amarin's Vascepa ® (icosapent ethyl) Demonstrates 26% Reduction in Key Secondary Composite E...TSXV:HLSHls Therapeutics
01/11/201811:30PR Newswire (Canada)HLS Therapeutics to Host 2018 Third Quarter Results Conference CallTSXV:HLSHls Therapeutics
24/09/201811:30PR Newswire (Canada)HLS Therapeutics Announces that Amarin's REDUCE-IT™ Cardiovascular Outcomes Study of Vascepa® (icosapent ethyl) Capsules M...TSXV:HLSHls Therapeutics
06/09/201812:30PR Newswire (Canada)HLS Therapeutics Appoints Tim Hendrickson as CFOTSXV:HLSHls Therapeutics
23/08/201800:08PR Newswire (Canada)HLS Therapeutics Announces Grant of Stock OptionsTSXV:HLSHls Therapeutics
15/08/201812:30PR Newswire (Canada)HLS Therapeutics Announces Q2 2018 Financial ResultsTSXV:HLSHls Therapeutics
30/07/201812:30PR Newswire (Canada)HLS Therapeutics to Host 2018 Second Quarter Results Conference CallTSXV:HLSHls Therapeutics
25/06/201812:30PR Newswire (Canada)HLS Therapeutics Reports Annual Meeting ResultsTSXV:HLSHls Therapeutics
15/06/201812:30PR Newswire (Canada)HLS Therapeutics to Host Annual Shareholder MeetingTSXV:HLSHls Therapeutics
30/05/201812:30PR Newswire (Canada)HLS Therapeutics Enters into Automatic Share Purchase PlanTSXV:HLSHls Therapeutics
16/05/201812:30PR Newswire (Canada)HLS Therapeutics Announces Q1 2018 Financial ResultsTSXV:HLSHls Therapeutics
09/05/201823:00PR Newswire (Canada)HLS Therapeutics Announces Normal Course Issuer BidTSXV:HLSHls Therapeutics
09/05/201812:30PR Newswire (Canada)HLS Therapeutics to Host 2018 First Quarter Results Conference CallTSXV:HLSHls Therapeutics
07/05/201812:30PR Newswire (Canada)HLS Appoints Ryan Lennox as General CounselTSXV:HLSHls Therapeutics
26/04/201812:30PR Newswire (Canada)HLS Therapeutics Announces Partial Redemption of Preferred SharesTSXV:HLSHls Therapeutics
20/04/201812:30PR Newswire (Canada)HLS to Present at the 2018 Bloom Burton & Co. Healthcare Investor ConferenceTSXV:HLSHls Therapeutics
29/03/201812:30PR Newswire (Canada)HLS Therapeutics Announces Fiscal 2017 Financial ResultsTSXV:HLSHls Therapeutics
19/03/201821:00PR Newswire (Canada)HLS Therapeutics to Host 2017 Fourth Quarter and Year End Results Conference CallTSXV:HLSHls Therapeutics
16/03/201816:00PR Newswire (Canada)HLS Therapeutics Inc. Opens the MarketTSXV:HLSHls Therapeutics
13/03/201821:15PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - GPLY; HLSTSXV:HLSHls Therapeutics
13/03/201821:13PR Newswire (Canada)IIROC Trading Resumption - GPLY; HLSTSXV:HLSHls Therapeutics
12/03/201823:01PR Newswire (Canada)HLS Therapeutics Completes Merger with Automodular CorporationTSXV:HLSHls Therapeutics
06/10/201022:19Marketwired CanadaTSX Venture Exchange Daily Bulletins for October 6, 2010TSXV:HLSHls Therapeutics
14/05/201022:50Marketwired CanadaTSX Venture Exchange Daily Bulletins for May 14, 2010TSXV:HLSHls Therapeutics
10/05/201015:44Marketwired CanadaSouthern Hemisphere Mining Limited: New Jorc Resource and Progress Update Los Pumas Manganese Project, ChileTSXV:HLSHls Therapeutics
06/05/201013:02Marketwired CanadaEurocontrol Technics Inc.: Athlone Global Security Investee Company Awarded Singapore Israel Industrial Research and DevelopmentTSXV:HLSHls Therapeutics
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:HLS

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
TEN
Tenaris
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
BAMI
Banco BPM
BIT
SRG
Snam
BIT
NEXI
Nexi S.p.A
BIT
SPM
Saipem
BIT
TRN
Terna Trasmissione Elett...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network